{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:27:43Z","timestamp":1787372863523,"version":"build-2736575974"},"reference-count":8,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7251-26","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:10:53Z","timestamp":1787091053000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Induction of IVIg Improved the Performance Status and Enabled Chemotherapy Initiation in PCD-LEMS: A Case Report"],"prefix":"10.2169","author":[{"given":"Tomohiro","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"},{"name":"Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yabata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kobashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Urushitani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"},{"name":"Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10: 1098-1107, 2011.","DOI":"10.1016\/S1474-4422(11)70245-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lipka AF, Boldingh MI, van Zwet EW, et al. Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome. Neurology 94: e511-e520, 2020.","DOI":"10.1212\/WNL.0000000000008747"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Maddison P, Gozzard P, Grainge MJ, Lang B. Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 88: 1334-1339, 2017.","DOI":"10.1212\/WNL.0000000000003794"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Velikova T, Sekulovski M, Bogdanova S, et al. Intravenous immunoglobulins as immunomodulators in autoimmune diseases and reproductive medicine. Antibodies (Basel) 12, 2023.","DOI":"10.3390\/antib12010020"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120: 1279-1300, 1997.","DOI":"10.1093\/brain\/120.8.1279"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lorenzoni PJ, Scola RH, Lang B, et al. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome. J Neurol Sci 270: 194-196, 2008.","DOI":"10.1016\/j.jns.2008.02.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moll JW, Henzen-Logmans SC, Van der Mech\u00e9 FG, Vecht CH. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 56: 112, 1993.","DOI":"10.1136\/jnnp.56.1.112"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grisold W, Drlicek M, Liszka-Setinek U, Wondrusch E. Anti-tumour therapy in paraneoplastic neurological disease. Clin Neurol Neurosurg 97: 106-111, 1995.","DOI":"10.1016\/0303-8467(95)00003-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7251-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:10:44Z","timestamp":1787371844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7251-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":8,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7251-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7251-26"}}